VRS
CPRX

Virginia Retirement Systems’s Catalyst Pharmaceutical CPRX Stock Holding History

Virginia Retirement Systems’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-46,900
Closed -$1.16M – 1312
2026
Q1 		$1.16M Buy
46,900
+8,300
+22% +$198K 0.01% 542
2025
Q4 		$901K Buy
38,600
+900
+2% +$20K 0.01% 623
2025
Q3 		$743K Buy
37,700
+4,500
+14% +$92.5K ﹤0.01% 672
2025
Q2 		$720K Buy
33,200
+19,400
+141% +$458K 0.01% 667
2025
Q1 		$335K Buy
+13,800
New +$311K ﹤0.01% 860
2023
Q3 		$1.5M Buy
128,000
+60,700
+90% +$812K 0.01% 404
2023
Q2 		$905K Buy
67,300
+22,700
+51% +$327K 0.01% 578
2023
Q1 		$739K Buy
44,600
+12,500
+39% +$206K 0.01% 625
2022
Q4 		$597K Sell
32,100
-27,700
-46% -$426K 0.01% 781
2022
Q3 		$767K Buy
+59,800
New +$709K 0.01% 666
2022
Q1 		$1.4M Buy
168,700
+88,500
+110% +$626K 0.01% 530
2021
Q4 		$543K Sell
80,200
-12,400
-13% -$81.5K ﹤0.01% 831
2021
Q3 		$491K Sell
92,600
-1,500
-2% -$8.2K 0.01% 794
2021
Q2 		$541K Buy
94,100
+26,500
+39% +$137K 0.01% 813
2021
Q1 		$312K Sell
67,600
-3,000
-4% -$11.9K ﹤0.01% 983
2020
Q4 		$236K Buy
70,600
+16,500
+30% +$55.4K ﹤0.01% 1028
2020
Q3 		$161K Sell
54,100
-15,000
-22% -$58.7K ﹤0.01% 1045
2020
Q2 		$319K Buy
69,100
+41,400
+149% +$186K ﹤0.01% 935
2020
Q1 		$107K Sell
27,700
-600
-2% -$2.46K ﹤0.01% 1047
2019
Q4 		$106K Sell
28,300
-7,000
-20% -$32.7K ﹤0.01% 1113
2019
Q3 		$187K Buy
+35,300
New +$188K ﹤0.01% 1079

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Virginia Retirement Systems's CPRX Position: Q2 2026 in Review

Virginia Retirement Systems sold out of Catalyst Pharmaceutical (CPRX) in Q2 2026, closing a stake of 46,900 shares — an estimated $1.16M sold.

Virginia Retirement Systems first reported a position in CPRX in Q3 2019 and held it in 21 quarters. The position peaked at $1.5M in Q3 2023. 396 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • Virginia Retirement Systems reported no remaining Catalyst Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • Virginia Retirement Systems sold 46,900 Catalyst Pharmaceutical shares in Q2 2026, an estimated $1.16M.
  • Virginia Retirement Systems first reported a position in Catalyst Pharmaceutical in Q3 2019 and held it in 21 quarters.
  • Virginia Retirement Systems's Catalyst Pharmaceutical position peaked at $1.5M in Q3 2023.
  • 396 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.